FI103043B1 - Menetelmä uusien, terapeuttisesti käyttökelpoisten 8-vinyyli- ja 8-etynyylikinolonikarboksyylihappojohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoiset välituotteet - Google Patents

Menetelmä uusien, terapeuttisesti käyttökelpoisten 8-vinyyli- ja 8-etynyylikinolonikarboksyylihappojohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoiset välituotteet

Info

Publication number
FI103043B1
FI103043B1 FI923268A FI923268A FI103043B1 FI 103043 B1 FI103043 B1 FI 103043B1 FI 923268 A FI923268 A FI 923268A FI 923268 A FI923268 A FI 923268A FI 103043 B1 FI103043 B1 FI 103043B1
Authority
FI
Finland
Prior art keywords
vinyl
preparation
useful
ethynylquinolone
carboxylic acid
Prior art date
Application number
FI923268A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI923268A0 (fi
FI103043B (fi
FI923268L (fi
Inventor
Uwe Petersen
Thomas Himmler
Thomas Schenke
Andreas Krebs
Klaus Grohe
Klaus-Dieter Bremm
Karl Georg Metzger
Rainer Endermann
Hans-Joachim Zeiler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Priority to FI970312A priority Critical patent/FI970312L/fi
Publication of FI923268A0 publication Critical patent/FI923268A0/fi
Publication of FI923268L publication Critical patent/FI923268L/fi
Application granted granted Critical
Publication of FI103043B publication Critical patent/FI103043B/fi
Publication of FI103043B1 publication Critical patent/FI103043B1/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Paints Or Removers (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
FI923268A 1991-07-19 1992-07-16 Menetelmä uusien, terapeuttisesti käyttökelpoisten 8-vinyyli- ja 8-etynyylikinolonikarboksyylihappojohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoiset välituotteet FI103043B1 (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI970312A FI970312L (fi) 1991-07-19 1992-07-16 8-halogeenikinoliinikarboksyylihappojohdannaiset

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4123918 1991-07-19
DE4123918A DE4123918A1 (de) 1991-07-19 1991-07-19 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren

Publications (4)

Publication Number Publication Date
FI923268A0 FI923268A0 (fi) 1992-07-16
FI923268L FI923268L (fi) 1993-01-20
FI103043B FI103043B (fi) 1999-04-15
FI103043B1 true FI103043B1 (fi) 1999-04-15

Family

ID=6436512

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923268A FI103043B1 (fi) 1991-07-19 1992-07-16 Menetelmä uusien, terapeuttisesti käyttökelpoisten 8-vinyyli- ja 8-etynyylikinolonikarboksyylihappojohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoiset välituotteet

Country Status (22)

Country Link
EP (1) EP0523512B1 (cs)
JP (1) JP3174405B2 (cs)
KR (1) KR100240608B1 (cs)
AT (1) ATE147733T1 (cs)
AU (1) AU658901B2 (cs)
CA (1) CA2073993A1 (cs)
CZ (1) CZ282037B6 (cs)
DE (2) DE4123918A1 (cs)
DK (1) DK0523512T3 (cs)
ES (1) ES2097835T3 (cs)
FI (1) FI103043B1 (cs)
GR (1) GR3022305T3 (cs)
HU (1) HU219910B (cs)
IE (1) IE80557B1 (cs)
IL (1) IL102520A (cs)
MX (1) MX9204110A (cs)
NO (1) NO302886B1 (cs)
PL (1) PL171910B1 (cs)
RU (1) RU2077533C1 (cs)
SK (1) SK219192A3 (cs)
TW (1) TW201309B (cs)
ZA (1) ZA925351B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4121214A1 (de) * 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
DE4303657A1 (de) * 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
DE4418510A1 (de) * 1994-05-27 1995-11-30 Bayer Ag 1,9-überbrückte Thiazolol[3,4-a]chinolinderivate
DE4425659A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Neue N1-diverse 6-Fluor-8-difluormethoxy substituierte Chinoloncarbonsäuren
DE4427530A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
CZ291251B6 (cs) * 1996-02-23 2003-01-15 Bayer Aktiengesellschaft Popřípadě substituované 8-kyan-1-cyklopropyl-7-(2,8-diazabicyklo-[4,3,0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarboxylové kyseliny a jejich deriváty, způsob jejich výroby, léčiva tyto látka obsahující a jejich pouľití
PT897919E (pt) 1996-04-19 2004-11-30 Wakunaga Pharma Co Ltd Novos derivados do acido piridonacarboxilico ou seus sais e agentes anti-bacterianos contendo-os como ingrediente activo
WO1998024781A1 (fr) * 1996-12-04 1998-06-11 Daiichi Pharmaceutical Co., Ltd. Derives d'aminomethylpyrrolidine substitue
PL339408A1 (en) 1997-09-15 2000-12-18 Procter & Gamble Antimicrobial quinolones, agents containing them and their applications
PT1666477E (pt) 2003-09-10 2013-08-28 Kyorin Seiyaku Kk Derivado de 7-(4-substituído-3-ciclopropilaminometil-1- pirrolidinil) quinolonecarboxílico
US7563805B2 (en) 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
RU2420524C2 (ru) * 2005-05-19 2011-06-10 Дайити Санкио Компани, Лимитед Производные три- или тетра-замещенного-3-аминопирролидина
US7842818B2 (en) 2005-09-28 2010-11-30 Daiichi Sankyo Company, Limited Process for preparation of tetrasubstituted 5-azaspiro[2.4]- heptane derivatives and optically active intermediates thereof
CA2647454A1 (en) 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates
EP2001862B1 (en) 2006-03-28 2011-04-27 Warner Chilcott Company, LLC Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
CA2688008A1 (en) 2007-05-24 2008-11-27 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
CN112074514B (zh) * 2018-05-09 2024-10-29 礼蓝动物保健有限公司 新的喹啉衍生物
RU2757741C1 (ru) * 2021-03-01 2021-10-21 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Производное ципрофлоксацина, обладающее антибактериальной активностью в отношении антибиотикоустойчивых штаммов микроорганизмов

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123536A (en) * 1977-12-14 1978-10-31 Warner-Lambert Company Dialkyl ({[3-(alkoxycarbonyl)-1,4-dihydro-4-oxo-8-quinolinyl]amino}methylene)propanedioates
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
US5047538A (en) * 1990-04-12 1991-09-10 Warner-Lambert Company Quinolinecarboxylic acid antibacterial agents

Also Published As

Publication number Publication date
EP0523512A1 (de) 1993-01-20
FI923268A0 (fi) 1992-07-16
IE922348A1 (en) 1993-01-27
NO922639D0 (no) 1992-07-03
CA2073993A1 (en) 1993-01-20
DE4123918A1 (de) 1993-01-21
HUT61741A (en) 1993-03-01
HU219910B (hu) 2001-09-28
ATE147733T1 (de) 1997-02-15
AU1966392A (en) 1993-01-21
IL102520A (en) 1997-07-13
AU658901B2 (en) 1995-05-04
SK279221B6 (sk) 1998-08-05
DE59207880D1 (de) 1997-02-27
EP0523512B1 (de) 1997-01-15
CZ282037B6 (cs) 1997-04-16
SK219192A3 (en) 1998-08-05
NO302886B1 (no) 1998-05-04
TW201309B (cs) 1993-03-01
DK0523512T3 (da) 1997-06-30
ZA925351B (en) 1993-04-28
FI103043B (fi) 1999-04-15
IE80557B1 (en) 1998-09-23
KR100240608B1 (ko) 2000-03-02
CZ219192A3 (en) 1993-02-17
PL171910B1 (pl) 1997-06-30
JPH05262738A (ja) 1993-10-12
GR3022305T3 (en) 1997-04-30
RU2077533C1 (ru) 1997-04-20
ES2097835T3 (es) 1997-04-16
KR930002320A (ko) 1993-02-22
MX9204110A (es) 1993-08-01
HU9202349D0 (en) 1992-10-28
FI923268L (fi) 1993-01-20
PL295331A1 (en) 1993-07-12
IL102520A0 (en) 1993-01-14
NO922639L (no) 1993-01-20
JP3174405B2 (ja) 2001-06-11

Similar Documents

Publication Publication Date Title
FI103043B1 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 8-vinyyli- ja 8-etynyylikinolonikarboksyylihappojohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoiset välituotteet
FI95255C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten merkaptoasetyyliamidopyrrolo- ja -pyridobentsatsepiinijohdannaisten valmistamiseksi
FI903696A0 (fi) Menetelmä antibakteeristen 5-alkyyli-6-fluori-1,4-dihydro-4-okso-1,8-naftyridiini-3-karboksyylihappojohdannaisten valmistamiseksi
FI875413A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten spiro-substituoitujen glutaarihappoamidien valmistamiseksi
PH25459A (en) Compound useful in the production of quinoline, naphthyridine carboxylic acids useful as antibacterials
FI104323B1 (fi) Menetelmä terapeuttisesti käyttökelpoisen 3-alkyyli-4-metyyli-4-(3-hydroksifenyyli)piperidiini-N-alkyylikarboksylaattien trans-3,4-isomeerien valmistamiseksi
FI104075B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-karboksitienyylikarbamoyylipyrrolidin-4-yylitiokarbapeneemi-3-karboksyylihappojohdannaisten valmistamiseksi
FI875319A0 (fi) Bisyklisten aminokarboksyylihappojen johdannaiset, menetelmä niiden valmistamiseksi ja niiden valmistuksessa käytettävät välituotteet, sekä niiden käyttö
FI890723A0 (fi) Menetelmä kinoliinikarboksyylihappojohdannaisten valmistamiseksi
FI97136B (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-metoksi-10-(1-hydroksietyyli)-11-okso-1-atsatrisyklo/7.2.0.03,8/-undek-2-eeni-2-karboksyylihappojen asyylioksialkyyliestereiden valmistamiseksi
YU47430B (sh) Supstituisani derivati azetidinil piridon karboksilnih kiselina i postupak njihove izrade
FI884752A7 (fi) Menetelmä uusien kinoliinijohdannaisten valmistamiseksi
DE68926148D1 (de) Solvate von einem Beta-Lactam-Antibiotikum
ES8802508A1 (es) Procedimiento para preparar derivados alquenicos.
ES2081674T3 (es) Derivados antibacterianos de los acidos 7-(aminometil-oxa-7-aza-biciclo-(3.3.0.)oct-7-il)quinolon- y naftiridon-carboxilico.
FI893250A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 1,4-diatsepiinijohdannaisten valmistamiseksi
DE3886151D1 (de) Kristallines Antibiotikum-Zwischenprodukt.
FI934054A0 (fi) Menetelmä antibakteeristen karboksyylihappojohdannaisten valmistuksessa käyttökelpoisten välituotteiden valmistamiseksi
ES2083961T3 (es) Acidos 3-anilino-2-hidroxicarbonil-4-tiofenoaceticos.
ATE144257T1 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren
ATE66453T1 (de) Herstellung von zwischenverbindungen fuer leukotrien-antagonisten.
FI901520A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kefeemikarbonyylihappoesterien valmistamiseksi
FI951697A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten hydroksialkylideenisyaanietikkahappoamidien valmistamiseksi
JPS6442488A (en) Production of 7-acylaminodeacetoxycephalosporanic acid or ester thereof
FI964117A0 (fi) Menetelmä uusien 1-asyylipiperidiiniyhdisteiden valmistamiseksi

Legal Events

Date Code Title Description
FG Patent granted

Owner name: BAYER AKTIENGESELLSCHAFT